These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 14672081

  • 1. Pacific nations lead the way in fighting lymphatic filariasis. Region aims to eliminate.
    Dean M.
    Lancet; 2003 Dec 06; 362(9399):1906. PubMed ID: 14672081
    [No Abstract] [Full Text] [Related]

  • 2. New goals set for filariasis elimination in India.
    Sharma DC.
    Lancet Infect Dis; 2002 Jul 06; 2(7):389. PubMed ID: 12127343
    [No Abstract] [Full Text] [Related]

  • 3. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P, Supali T, Maizels RM.
    Trends Parasitol; 2004 Aug 06; 20(8):351-5. PubMed ID: 15246315
    [Abstract] [Full Text] [Related]

  • 4. Pacific collaboration to eliminate lymphatic filariasis.
    Ichimori K, Crump A.
    Trends Parasitol; 2005 Oct 06; 21(10):441-4. PubMed ID: 16099721
    [Abstract] [Full Text] [Related]

  • 5. Elimination of lymphatic filariasis.
    Michael E, Malecela-Lazaro MN, Kazura JW.
    Lancet; 2006 Jul 29; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
    [No Abstract] [Full Text] [Related]

  • 6. Improving community participation to eliminate lymphatic filariasis in American Samoa.
    King JD, Zielinski-Gutierrez E, Pa'au M, Lammie P.
    Acta Trop; 2011 Sep 29; 120 Suppl 1():S48-54. PubMed ID: 20932818
    [Abstract] [Full Text] [Related]

  • 7. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
    Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, Whitfeld MJ, King CL, Weil GJ, Grobler AC, Robinson LJ, Kaldor JM, Steer AC.
    Clin Infect Dis; 2021 Sep 15; 73(6):994-1002. PubMed ID: 33728462
    [Abstract] [Full Text] [Related]

  • 8. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May 16; 78(20):171-9. PubMed ID: 12808788
    [No Abstract] [Full Text] [Related]

  • 9. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU, King CL, Jacobson JA, Weil GJ.
    PLoS Negl Trop Dis; 2017 Jan 16; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract] [Full Text] [Related]

  • 10. The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
    Rainima-Qaniuci M, Lepaitai HB, Bhagirov R, Padmasiri E, Naseri T, Thomsen R, Won KY, Brant TA, Dodd E, Nua MT, Utu F, Tufa A, Chutaro E, Camacho J, Suiaunoa-Scanlan L, Thean LJ, Mani J, Hardy M, Samuela J, Romani L, Kaldor J, Steer AC, Faktaufon D, Bechu V, Naqio F, Sosene V, Sekihara M, Otaki J, Buhagiar TS, Yajima A.
    Am J Trop Med Hyg; 2022 May 11; 106(5_Suppl):39-47. PubMed ID: 35292579
    [Abstract] [Full Text] [Related]

  • 11. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR, Taleo G, Toeaso V, Ichimori K.
    Ann Trop Med Parasitol; 2002 Dec 11; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [Abstract] [Full Text] [Related]

  • 12. Albendazole for mass drug administration to eliminate lymphatic filariasis.
    Sabesan S.
    Lancet Infect Dis; 2006 Nov 11; 6(11):684-5. PubMed ID: 17067916
    [No Abstract] [Full Text] [Related]

  • 13. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.
    Dreyer G, Norões J, Figueredo-Silva J, Piessens WF.
    Parasitol Today; 2000 Dec 11; 16(12):544-8. PubMed ID: 11121854
    [Abstract] [Full Text] [Related]

  • 14. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA, Ismail MM, Horton J.
    Parasitol Today; 1999 Sep 11; 15(9):382-6. PubMed ID: 10461168
    [Abstract] [Full Text] [Related]

  • 15. Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole.
    Selve BP, Bwadua S, Misa M, James K, Usurup JP, Turner P, Melrose W, Yad W, Samuel R, Eddie C.
    P N G Med J; 2000 Sep 11; 43(3-4):183-7. PubMed ID: 11939299
    [Abstract] [Full Text] [Related]

  • 16. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
    Gunawardena GS, Ismail MM, Bradley MH, Karunaweera ND.
    Ann Trop Med Parasitol; 2007 Jun 11; 101(4):335-41. PubMed ID: 17524248
    [Abstract] [Full Text] [Related]

  • 17. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
    McCarthy J.
    Am J Trop Med Hyg; 2005 Aug 11; 73(2):232-3. PubMed ID: 16103580
    [No Abstract] [Full Text] [Related]

  • 18. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2004 Oct 01; 79(40):358-65. PubMed ID: 15631012
    [No Abstract] [Full Text] [Related]

  • 19. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
    McLure A, Graves PM, Lau C, Shaw C, Glass K.
    Epidemics; 2022 Sep 01; 40():100591. PubMed ID: 35816826
    [Abstract] [Full Text] [Related]

  • 20. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD.
    Trends Parasitol; 2009 Jan 01; 25(1):7-8. PubMed ID: 19008150
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.